NVCT Market Cap History

Below is a table of the NVCT market cap history going back to 11/7/2022:

Date NVCT Market Cap

Also see: NVCT Shares Outstanding History
and NVCT YTD Return
NVCT Historical Market Cap:
+28.28% CAGR
NVCT Historical Market Cap: +28.28% CAGR

Mouse over chart for data details
Nuvectis Pharma is a biopharmaceutical company focused on the development of medicines for the treatment of medical needs in oncology. Co. uses target selection, drug profiling, and clinical and regulatory execution to build a pipeline of anticancer targeted-therapy drugs. Co. is developing two preclinical drug candidates, NXP800 and NXP900. NXP800 is an oral small molecule inhibitor of the Heat Shock Factor 1 pathway. NXP800 targets ovarian clear cell carcinoma and endometrioid ovarian cancer. NXP900 is an oral small molecule designed to inhibit the SRC and YES1 kinases. NXP900 is in preclinical development with IND-enabling studies. We show 7 historical shares outstanding datapoints in our NVCT shares outstanding history coverage, used to compute NVCT market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NVCT market cap history over the course of time is important for investors interested in comparing NVCT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NVCT versus a peer is one thing; comparing NVCT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NVCT can fluctuate over the course of history. With this page we aim to empower investors researching NVCT by allowing them to research the NVCT market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree NVCT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Nuvectis Pharma (NVCT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

NVIV Market Cap History
NVNO Market Cap History
NVO Market Cap History
NVOS Market Cap History
NVRO Market Cap History
NVST Market Cap History
NVTA Market Cap History
NVTR Market Cap History
NVUS Market Cap History
NXL Market Cap History
More Healthcare companies »


NVCT Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.